Hospitalist Doctors in Mount Vernon, WA Accepting Medicare

5 Hospitalist doctors found. Showing 1 - 5

Bonita K. Baker, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1415 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-416-5750    Fax: 360-416-5758

D. Geoffrey Spielmann, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1415 E. Kincaid St., Skagit Valley Hospital, Mount Vernon, WA 98274 Phone: 360-416-5750    Fax: 360-416-4758

Malik F. Fuimaono, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1415 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-416-5750    Fax: 360-416-5758

Assem Botros Sherkawy, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-416-5750    Fax: 360-416-5758

Dr. Thomas V George, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1415 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-416-5750    Fax: 360-416-5758

News Archive

CPEB4 protein plays a crucial role in cancer progression

A study by researchers Ra-l M-ndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona) and Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) describes a new reprogramming mechanism for the expression of genes responsible for turning a healthy cell into a tumor cell.

One out of four people don't know they have hypertension

High blood pressure is a major risk factor for heart attack, stroke, and renal failure, but one out of four people don't even know they have it.

Aptuit announces strategic partnership Siena Biotech

Aptuit, Inc., and Siena Biotech S.p.A., today announced a strategic partnership in which Siena Biotech will take a minority stake in Aptuit's Italian operations in Verona, Italy, and Aptuit will become a provider of choice for Siena Biotech's development pipeline. Under the agreement Aptuit and Siena Biotech will work collaboratively on the development of Siena Biotech's pipeline of compounds, focused in three key therapeutic areas, including Alzheimer's disease, Huntington's disease and oncology.

FDA permits marketing of 23andme Personal Genome Service Pharmacogenetic Reports test

Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.

Illumina to defend Genome Analyzer System patent infringement suit

Illumina, Inc. today announced that it has been served with a complaint filed on September 21, 2009 in the U.S. District Court in Wilmington, Delaware naming Illumina as a defendant. The complaint names as plaintiffs Life Technologies Corporation; Applied Biosystems LLC; a Russian research institute; two individuals listed as inventors on the asserted patents; and another individual who appears to have an ownership interest in the patents.

Read more Medical News

› Verified 3 days ago